{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:86289106",
      "entity_text" : "EEG",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01553",
      "entity_text" : "MK-801",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Treatment with MK-801, a highly potent, selective glutamate antagonist, between 6 and 24 h after cerebral ischemia prevented delayed post-ischemic seizures and completely suppressed fetal EEG activity.",
  "reading_complete" : "2020-08-05T20:53:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:50:43Z",
  "trigger" : "suppressed",
  "evidence" : [ "MK-801, a highly potent, selective glutamate antagonist, between 6 and 24 h after cerebral ischemia prevented delayed post-ischemic seizures and completely suppressed fetal EEG" ],
  "pmc_id" : "3936504",
  "score" : 0
}